| 1. | The first, vismodegib, was FDA-approved in 2012, for treating basal cell carcinoma.
|
| 2. | For basal cell cancer, the risk was 1 . 5 time greater.
|
| 3. | K5 may therefore be useful in the identification of basal cell metastases.
|
| 4. | Overexpression causes an increase in neuroendocrine, gastric / intestinal and basal cells.
|
| 5. | This regulatory circuit provides functional control over basal cell proliferation and differentiation.
|
| 6. | Another 2, 000 will die of basal cell or squamous cell cancers.
|
| 7. | Basal cell carcinomas rarely spread and deaths from them are rare.
|
| 8. | The olfactory epithelium consists of olfactory sensory cells, sustentacular cells and basal cells.
|
| 9. | Physical findings typically include follicular atrophoderma, multiple basal cell carcinomas, hypotrichosis, and hypohidrosis.
|
| 10. | In one study, researchers incorporated tritiated thymidine into dividing murine epidermal basal cells.
|
मोबाइल